ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : PROGESTIN RECEPTORS
Field of Research : Innate Immunity
Clear All
Filter by Field of Research
Innate Immunity (17)
Receptors and Membrane Biology (5)
Biochemistry and Cell Biology (4)
Cellular Immunology (2)
Animal Physiology - Systems (1)
Central Nervous System (1)
Neurosciences (1)
Respiratory Diseases (1)
Filter by Socio-Economic Objective
Expanding Knowledge in the Biological Sciences (2)
Immune System and Allergy (2)
Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified (1)
Health Related to Ageing (1)
Infectious Diseases (1)
Livestock Raising not elsewhere classified (1)
Nervous System and Disorders (1)
Neurodegenerative Disorders Related to Ageing (1)
Specific Population Health (excl. Indigenous Health) not elsewhere classified (1)
Filter by Funding Provider
National Health and Medical Research Council (12)
Australian Research Council (5)
Filter by Status
Closed (15)
Active (2)
Filter by Scheme
Project Grants (5)
Discovery Projects (2)
NHMRC Project Grants (2)
Research Fellowships (2)
ARC Future Fellowships (1)
Career Development Fellowships (1)
Early Career Fellowships (1)
Linkage Infrastructure, Equipment and Facilities (1)
Linkage Projects (1)
Postgraduate Scholarships (1)
Filter by Country
Australia (6)
Filter by Australian State/Territory
VIC (4)
NSW (2)
WA (1)
  • Researchers (14)
  • Funded Activities (17)
  • Organisations (15)
  • Funded Activity

    Pattern Recognition Receptors In Inflammation And Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $622,655.00
    Summary
    Innate immunity provides our first line of defence against infections, but pathogens can overcome this system. Understanding how microbes disable innate immunity can teach us how to prevent and/or treat infectious diseases. Innate immunity acts by initiating inflammation. Many important acute and chronic diseases develop when this process is dysregulated. Blocking innate immunity thus has potential to treat many diseases. This project aims to understand innate immunity in these contexts.
    More information
    Funded Activity

    Dampening Inflammation With Flightless

    Funder
    National Health and Medical Research Council
    Funding Amount
    $398,908.00
    Summary
    Excess inflammation is a major problem after injury and in many diseases. Upon injury molecules are release that act as danger signals to alert the immune system to start the repair process. However, high levels of these dangers signals can impair the final stages of healing. Understanding how to prevent the immune system being excessively stimulated by these danger signals is key to being able to dampen inflammation after injury improve the healing response.
    More information
    Funded Activity

    Investigation Of The Use Of Innate And CD1-mediated Immune Responses As Biomarkers In Tuberculosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $144,836.00
    Summary
    Tuberculosis and other non-tuberculosis mycobacterial infections are major health problems worldwide. There are multiple challenges facing treatment and identification of active versus latent TB infections currently. This project aims to identify and characterise several aspects of the immune system which may be responsible for people developing active infections, including ones which may enable development of diagnostic tests and to monitor treatment. Such a biomarker may also help hasten new d .... Tuberculosis and other non-tuberculosis mycobacterial infections are major health problems worldwide. There are multiple challenges facing treatment and identification of active versus latent TB infections currently. This project aims to identify and characterise several aspects of the immune system which may be responsible for people developing active infections, including ones which may enable development of diagnostic tests and to monitor treatment. Such a biomarker may also help hasten new drug therapies for tuberculosis.
    Read more Read less
    More information
    Funded Activity

    The Identification And Characterisation Of A New DNA Receptor

    Funder
    National Health and Medical Research Council
    Funding Amount
    $656,498.00
    Summary
    The immune system has evolved to fight disease-causing microbes. First, it has to recognize that an infectious agent has invaded. To do this we have developed many probes (receptors) that sense microbial products. Detecting microbial DNA is a critical alarm bell. However, distinguishing pathogen DNA from our own DNA is difficult because both look alike. We have identified a new receptor that helps us identify bacterial DNA and alerts the immune system to the imminent danger.
    More information
    Funded Activity

    The Inflammasome In Host Defence And Autoinflammation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $408,388.00
    Summary
    Inflammation is one of the bodies first responses to infection. The inflammasome is a protein complex that activates pro-inflammatory cytokines as part of this process. We are investigating pathogens that activate a specific inflammasome complex, and also an inflammatory disease it may cause when activated accidentally, in the absence of infection. We are also investigating pathways that keep this inflammation in check, and how pathogens might hijack these anti-inflammatory pathways to promote i .... Inflammation is one of the bodies first responses to infection. The inflammasome is a protein complex that activates pro-inflammatory cytokines as part of this process. We are investigating pathogens that activate a specific inflammasome complex, and also an inflammatory disease it may cause when activated accidentally, in the absence of infection. We are also investigating pathways that keep this inflammation in check, and how pathogens might hijack these anti-inflammatory pathways to promote infection.
    Read more Read less
    More information
    Funded Activity

    The Role Of BAFF, Its Receptor TACI And Toll-like Receptors In Autoimmunity And Tolerance.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $486,824.00
    Summary
    There are 2 types of immune cells, innate cells reacting broadly against microbial elements, and adaptive cells educated to remember pathogens and provide improved immune responses. Most treatments against lupus target the adaptive cells with mixed success. We have discovered a new mechanism driving lupus at the level of innate immunity. This proposal will identify molecular players driving this unappreciated form of lupus and validate new therapeutic targets.
    More information
    Funded Activity

    Recognition And Interaction Of Virus By The Innate Immune System

    Funder
    National Health and Medical Research Council
    Funding Amount
    $307,946.00
    Summary
    The innate immune system acts rapidly to limit infection of invading pathogens. The interaction and recognition of pathogens such as viruses by the innate immune system, is of importance to understand why particular pathogens induce disease.
    More information
    Funded Activity

    Initial Interactions Of Herpes Simplex Virus With Innate Immune Cells In Human Skin

    Funder
    National Health and Medical Research Council
    Funding Amount
    $522,589.00
    Summary
    Herpes simplex viruses 1 and 2 cause widespread and occasionally serious diseases including genital herpes, neonatal death and encephalitis. Current vaccine candidates are at best partially effective. This grant will examine the way that the virus enters, initially spreads within the skin and interacts with immune cells to help determine which cells should be stimulated by vaccines.
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE160100097

    Funder
    Australian Research Council
    Funding Amount
    $675,000.00
    Summary
    An Automated Protein Nano-Crystallisation Facility. An automated protein nano-crystallisation facility: The project aims to establish a high throughput protein nanocrystallisation and imaging facility for protein crystallography. Protein crystallography is an important field of biological research, however there are many proteins, such as integral membrane proteins and transient molecular complexes that are more challenging to crystallise. The facility aims to use state-of-the-art imaging and c .... An Automated Protein Nano-Crystallisation Facility. An automated protein nano-crystallisation facility: The project aims to establish a high throughput protein nanocrystallisation and imaging facility for protein crystallography. Protein crystallography is an important field of biological research, however there are many proteins, such as integral membrane proteins and transient molecular complexes that are more challenging to crystallise. The facility aims to use state-of-the-art imaging and crystallisation techniques, including second order nonlinear imaging of chiral crystals (SONICC) imaging and lipid cubic phase approaches, to enable structural studies to be undertaken on challenging proteins. This information is often used for the rational development of therapeutics. The facility would support cutting-edge biological research In Australia.
    Read more Read less
    More information
    Active Funded Activity

    Discovery Projects - Grant ID: DP220102288

    Funder
    Australian Research Council
    Funding Amount
    $597,830.00
    Summary
    A novel axis of cooperation between innate and adaptive immunity. The project aims to understand how two molecular components of the immune system, Complement and MHC, cooperate to protect the host. Further, these two molecules mediate trogocytosis, a little-studied form of intercellular communication, between two major immune cell types: dendritic cells and B cells. The project will be multidisciplinary, applying high-end microscopy, biochemistry, cell biology and immunology techniques. Person .... A novel axis of cooperation between innate and adaptive immunity. The project aims to understand how two molecular components of the immune system, Complement and MHC, cooperate to protect the host. Further, these two molecules mediate trogocytosis, a little-studied form of intercellular communication, between two major immune cell types: dendritic cells and B cells. The project will be multidisciplinary, applying high-end microscopy, biochemistry, cell biology and immunology techniques. Personnel will be trained in cutting-edge techniques. The project will expand knowledge on basic immunology and cell-cell cooperation. It will generate intellectual property for the biotechnology sector to develop new commercial products that might improve the health of humans and also animals of economic importance.
    Read more Read less
    More information

    Showing 1-10 of 17 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback